USANA Health Sciences Reports Strong Second Quarter 2011 Financial Results
-- Net sales increase by 18.2% to $148.9 million -- Earnings per share increase by 27.5% to $0.88 -- Company raises outlook for 2011
SALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NYSE: USNA) today reported financial results for its fiscal second quarter ended July 2, 2011, which were stronger than the preliminary results announced on June 29, 2011.
Net sales in the second quarter of 2011 increased by 18.2% to $148.9 million, compared with $126.0 million in the second quarter of the prior year. Higher product sales and an increased number of active Associates in the Company's Asia Pacific region were the primary drivers of this growth. Favorable changes in currency exchange rates added $5.9 million to sales during the quarter, and BabyCare, the Company's operating entity in China, added $5.6 million to sales.
Net earnings in the second quarter increased by 28.7% to $13.9 million, or $0.88 per share, compared with $0.69 per share in the second quarter of the prior year. Net earnings growth resulted from improved gross profit margins on higher net sales and lower relative selling, general and administrative expenses. Earnings per share for the period benefited by $0.06 due to the recapture of unvested equity compensation expense related to the departure of certain executives from the Company.
Chief Executive Officer Dave Wentz said, "Our team generated solid performance during the second quarter, despite unanticipated changes and challenges. The execution of our strategic plan by the management team and Associate sales force, in light of these challenges, reflects the strength of the underlying business and the dedication of our people. A major factor behind our performance, and confidence in the future, is the synergy that exists between the management team and our Associate leaders. We believe that this relationship is as strong as ever."
For the six months ended July 2, 2011, net sales increased by 19.3% to $292.5 million, compared with $245.1 million in the prior year. This growth was driven by higher product sales and an increased number of active Associates in the Asia Pacific region. For this period, BabyCare added $11.3 million to sales, and favorable changes in currency exchange rates accounted for $10.0 million of the $47.4 million increase.
Net earnings for the six months ended July 2, 2011 increased by 23.5% to $25.2 million, or $1.58 per share, compared with $1.31 per share in the prior year. This net earnings growth resulted from significantly improved gross profit margins on higher sales. These improvements were partially offset by higher selling, general, and administrative expenses that can primarily be attributed to the inclusion of BabyCare's operations.
Net sales in the Asia Pacific region for the second quarter of 2011 increased by 38.7% to $88.7 million, compared with the second quarter of the prior year. This improvement was due to strong growth in Hong Kong, South Korea, and the Philippines, as well as the addition of BabyCare. In the second quarter, the number of active Associates in this region increased by 20.9%, which was primarily the result of double-digit growth in Hong Kong, South Korea, and the Philippines, as well as the inclusion of 14,000 BabyCare Associates. On a sequential quarter basis, net sales and the number of Active Associates in the region increased 6.1% and 6.9%, respectively.
"The performance from our Asia Pacific region was particularly impressive given the strategic changes that occurred during the quarter and the competitive pressures that currently exist in this region," continued Mr. Wentz. "Our Asia Pacific team, led by Deborah Woo, is to be credited for our strong growth in the region and for the improvements to our China integration strategy. Our management team is confident that the modified integration approach for BabyCare will drive long-term, sustainable growth in this region. In addition to our recent entry into China, we are expanding our international operations into Thailand in the fourth quarter of 2011, and we plan to be more aggressive in our international expansion efforts in the near future."
During the second quarter of 2011, net sales in the North America region decreased by three percent to $60.3 million, compared with the second quarter of the prior year. The number of Active Associates in the North America region during this period also declined by 12.6%, compared with the second quarter of the prior year. On a sequential quarter basis, sales in this region were up slightly and the number of Active Associates was flat.
"We remain committed to growing our North America region," added Mr. Wentz. "Our North America team, led by Kevin Guest, and Associate leaders are working closely together to achieve this goal. The strategies that we are evaluating for this region include product innovation and customization initiatives, as well as incentive offerings for our Associates to reward top performers. In August 2011, we will hold our 19th Annual International Convention in Salt Lake City, where we expect Associates from each of our 15 markets will attend. This event provides an excellent opportunity to introduce new programs and incentives, while training and motivating our Associates."
Chief Financial Officer Doug Hekking commented, "Based on the strength of our results in the first half of the year, we are raising our outlook for 2011. We now project consolidated net sales to be between $565 million and $575 million for the year, versus our previous outlook of $530 million to $550 million. In addition, we now expect to generate earnings per share between $3.05 and $3.10 versus our previous outlook of $2.85 to $2.95. This renewed outlook reflects the continued integration of BabyCare into our business, as well as the competitive challenges that we will likely face in the second half of the year. We remain committed to the goal of delivering growth in each of our markets, with a continued focus on operational efficiency. Overall, we expect USANA to finish off a strong 2011 and to deliver our ninth consecutive year of record financial performance."
USANA will hold a conference call and webcast to discuss this announcement with investors on Wednesday, July 27, 2011 at 11:00AM Eastern Time. Investors may listen to the call by accessing USANA's website at http://www.usanahealthsciences.com.
USANA develops and manufactures high-quality nutritional, personal care, and weight-management products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, and the United Kingdom. Additionally, USANA's wholly-owned subsidiary, BabyCare, Ltd., operates a direct selling business in China. More information on USANA can be found at http://www.usanahealthsciences.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
USANA Health Sciences, Inc. Consolidated Statements of Earnings (In thousands, except per share data) (Unaudited) Quarter Ended 3-Jul-10 2-Jul-11 Net sales $ 126,011 $ 148,925 Cost of sales 22,735 26,208 Gross profit 103,276 122,717 Operating expenses Associate incentives 57,065 67,760 Selling, general and administrative 29,149 33,803 Earnings from operations 17,062 21,154 Other income (expense) (587 ) - Earnings before income taxes 16,475 21,154 Income taxes 5,705 7,298 NET EARNINGS $ 10,770 $ 13,856 Earnings per share - diluted $ 0.69 $ 0.88 Weighted average shares outstanding - diluted 15,697 15,752 USANA Health Sciences, Inc. Consolidated Balance Sheets (In thousands) As of As of 1-Jan-11 2-Jul-11 (Unaudited) ASSETS Current Assets Cash and cash equivalents $ 24,222 $ 24,944 Inventories 34,078 35,381 Other current assets 21,972 18,932 Total current assets 80,272 79,257 Property and equipment, net 57,568 60,564 Goodwill 16,930 16,930 Other assets 49,032 49,177 Total assets $ 203,802 $ 205,928 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Accounts payable $ 6,445 $ 8,345 Other current liabilities 51,179 46,144 Total current liabilities 57,624 54,489 Other long-term liabilities 1,012 1,020 Stockholders' equity 145,166 150,419 Total liabilities and stockholders' equity $ 203,802 $ 205,928
USANA Health Sciences, Inc. Sales by Region (Unaudited) (In thousands) Quarter Ended 3-Jul-10 2-Jul-11 Region North America United States $ 37,992 30.1 % $ 37,121 25.0 % Canada 18,373 14.6 % 17,462 11.7 % Mexico 5,748 4.6 % 5,684 3.8 % North America Total 62,113 49.3 % 60,267 40.5 % Asia Pacific Southeast Asia/Pacific 23,968 19.0 % 27,225 18.3 % Greater China 34,437 27.3 % 53,678 36.0 % North Asia 5,493 4.4 % 7,755 5.2 % Asia Pacific Total 63,898 50.7 % 88,658 59.5 % Total $ 126,011 100.0 % $ 148,925 100.0 % Active Associates by Region(1) (Unaudited) As of 3-Jul-10 2-Jul-11 Region North America United States 57,000 27.1 % 49,000 22.1 % Canada 26,000 12.4 % 24,000 10.8 % Mexico 12,000 5.7 % 10,000 4.5 % North America Total 95,000 45.2 % 83,000 37.4 % Asia Pacific Southeast Asia/Pacific 44,000 21.0 % 43,000 19.4 % Greater China 63,000 30.0 % 87,000 39.2 % North Asia 8,000 3.8 % 9,000 4.0 % Asia Pacific Total 115,000 54.8 % 139,000 62.6 % Total 210,000 100.0 % 222,000 100.0 %
(1) Associates are independent distributors of our products who also purchase our products for their personal use. We only count as active those Associates who have purchased product at any time during the most recent three-month period, either for personal use or for resale.
Active Preferred Customers by Region(2) (Unaudited) As of 3-Jul-10 2-Jul-11 Region North America United States 39,000 59.1 % 37,000 54.4 % Canada 15,000 22.7 % 13,000 19.1 % Mexico 3,000 4.6 % 3,000 4.4 % North America Total 57,000 86.4 % 53,000 77.9 % Asia Pacific Southeast Asia/Pacific 6,000 9.1 % 6,000 8.8 % Greater China 2,000 3.0 % 8,000 11.8 % North Asia 1,000 1.5 % 1,000 1.5 % Asia Pacific Total 9,000 13.6 % 15,000 22.1 % Total 66,000 100.0 % 68,000 100.0 %
(2) Preferred Customers purchase our products strictly for their personal use and are not permitted to resell or to distribute the products. We only count as active those Preferred Customers who have purchased product at any time during the most recent three-month period.
Source: USANA Health Sciences, Inc.
Released July 26, 2011